Giovanna Valenti Selected Research

Aquaporin 2

3/2019	Comparison between men and women of volume regulating hormones and aquaporin-2 excretion following graded central hypovolemia.
10/2014	A protein kinase A-independent pathway controlling aquaporin 2 trafficking as a possible cause for the syndrome of inappropriate antidiuresis associated with polycystic kidney disease 1 haploinsufficiency.
1/2012	Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study.
10/2011	Altered urinary excretion of aquaporin 2 in IgA nephropathy.
1/2007	Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus.
1/2005	Renal function in space: the link between osteoporosis, hypercalciuria, and aquaporins.
12/2004	Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells.
10/2004	Selective decrease in urinary aquaporin 2 and increase in prostaglandin E2 excretion is associated with postobstructive polyuria in human congenital hydronephrosis.
10/2000	Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Valenti Research Topics

Disease

7	Hypercalciuria 01/2022 - 10/2000
7	Hypertension (High Blood Pressure) 01/2021 - 01/2011
6	Nephrogenic Diabetes Insipidus 01/2021 - 12/2005
5	Autosomal Dominant Polycystic Kidney (ADPKD) 10/2021 - 01/2018
5	Polyuria 01/2019 - 10/2004
4	Nephrogenic Syndrome of Inappropriate Antidiuresis 01/2021 - 01/2019
4	Neoplasms (Cancer) 12/2018 - 12/2013
3	Cysts 10/2021 - 06/2007
3	Hyponatremia 01/2020 - 10/2019
2	Dehydration (Water Stress) 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2018
2	Hypotension (Low Blood Pressure) 03/2015 - 01/2011
2	Chronic Renal Insufficiency 03/2015 - 10/2011
2	Goiter 01/2013 - 01/2011
2	Deafness (Deaf Mutism) 01/2013 - 01/2011
2	Pendred syndrome 01/2013 - 01/2011
2	Enuresis 11/2002 - 10/2000
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2022
1	Orthostatic Intolerance 01/2022
1	Vascular Calcification 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Inappropriate ADH Syndrome (SIADH) 01/2021
1	Obesity 03/2020
1	Hepatocellular Carcinoma (Hepatoma) 03/2020
1	Hypovolemia 03/2019
1	Polydipsia 01/2019
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2018
1	Chromosomal Instability (Chromosome Stability) 12/2018
1	Aneuploidy (Aneuploid) 12/2018
1	Atherosclerosis 01/2018
1	Frailty 01/2018
1	Asthma (Bronchial Asthma) 01/2017
1	Respiratory Hypersensitivity 01/2017
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 02/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Syncope (Fainting) 07/2015
1	Urolithiasis 03/2015
1	Renal Insufficiency (Renal Failure) 10/2014
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2014
1	Glomerulonephritis 12/2013
1	Stroke (Strokes) 12/2013
1	Hypocalcemia 01/2013
1	Bartter Syndrome (Syndrome, Bartter) 01/2013
1	Alkalosis 01/2013
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2011
1	Proteinuria 10/2011

Drug/Important Bio-Agent (IBA)

14	Vasopressins (Vasopressin)IBA 10/2021 - 10/2000
9	Aquaporin 2IBA 03/2019 - 10/2000
7	CalciumIBA 10/2021 - 11/2002
6	Calcium-Sensing ReceptorsIBA 01/2022 - 12/2004
5	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2021 - 06/2007
5	Aquaporins (Water Channels)IBA 10/2014 - 01/2002
3	SaltsIBA 08/2011 - 01/2011
2	Parathyroid Hormone (Parathormone)IBA 01/2022 - 01/2013
2	lixivaptanIBA 10/2021 - 12/2019
2	Hormones (Hormone)IBA 03/2019 - 02/2016
2	Calcibiotic Root Canal SealerIBA 12/2018 - 10/2018
2	Peptides (Polypeptides)IBA 03/2015 - 10/2005
2	IodidesIBA 01/2013 - 01/2011
2	Pharmaceutical PreparationsIBA 01/2012 - 10/2011
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 10/2021
1	WastewaterIBA 12/2020
1	Biological ProductsIBA 12/2020
1	Nonesterified Fatty Acids (NEFA)IBA 03/2020
1	NF-kappa B (NF-kB)IBA 03/2020
1	Tolvaptan FDA Link 12/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2019
1	Epidermal Growth Factor (EGF)IBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	ZincIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	Theophylline (Theon)FDA LinkGeneric 01/2017
1	Interleukin-13IBA 01/2017
1	Free RadicalsIBA 01/2016
1	AdrenomedullinIBA 07/2015
1	GalaninIBA 07/2015
1	Arginine Vasopressin (Argipressin)IBA 03/2015
1	Amino Acids FDA Link 03/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2014
1	RoscovitineIBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2013
1	ChloridesIBA 01/2012
1	benzofuranIBA 01/2012
1	Chloride Channels (Chloride Channel)IBA 01/2012
1	Furosemide (Lasix)FDA LinkGeneric 08/2011
1	Adenosine Triphosphatases (ATPase)IBA 08/2011
1	Member 1 Solute Carrier Family 12IBA 08/2011
1	SodiumIBA 07/2011
1	adducinIBA 07/2011

Therapy/Procedure

2	Bed Rest (Bedrest) 01/2022 - 07/2015
2	Lower Body Negative Pressure 03/2019 - 07/2015